Diagnostic Chemical Analyzer Menu Expanded to Include HbA1c
|
By LabMedica International staff writers Posted on 11 Mar 2010 |
A compact, semiautomated, clinical chemistry analyzer for routine and specialized diagnostic testing has added HbA1c to its menu.
The new test is run on an analyzer, the RX monza, and results are achieved rapidly and easily. The analyzer offers excellent specificity, precision, and sensitivity. It is a tough and reliable system, which requires little maintenance and is suited to a variety of laboratory settings including clinical laboratories and specialized clinics.
The RX monza offers more than 120 programmable tests, one-touch or two-touch direct-access keys, and full on-board quality control (QC). The instrument includes intelligent, easy-to-use software and can store up to 1000 sample results. Supplementary QC software packages are available 24/7.
A product of Randox (Crumlin, UK), the RX monza test menu includes routine clinical chemistry, cardiac, lipids, diabetes, antioxidants, renal function, liver function, electrolytes, veterinary testing, and food and wine testing.
The HbA1c test is used for routine monitoring of diabetic or at-risk people, to help prevent long-term complications of the condition. Diabetes-related complications are reduced by long term monitoring and tight control of blood glucose levels. Because red blood cells have a life span of 4 months, HbA1c gives an indication of long-term control of the patient's blood sugar levels and compliance with his/her diet.
Diabetes is a chronic and progressive disease that affects almost every aspect of life. The disease can result in premature death, ill health, and disability, conditions that can be prevented or delayed by high quality management and care.
Related Links:
Randox
The new test is run on an analyzer, the RX monza, and results are achieved rapidly and easily. The analyzer offers excellent specificity, precision, and sensitivity. It is a tough and reliable system, which requires little maintenance and is suited to a variety of laboratory settings including clinical laboratories and specialized clinics.
The RX monza offers more than 120 programmable tests, one-touch or two-touch direct-access keys, and full on-board quality control (QC). The instrument includes intelligent, easy-to-use software and can store up to 1000 sample results. Supplementary QC software packages are available 24/7.
A product of Randox (Crumlin, UK), the RX monza test menu includes routine clinical chemistry, cardiac, lipids, diabetes, antioxidants, renal function, liver function, electrolytes, veterinary testing, and food and wine testing.
The HbA1c test is used for routine monitoring of diabetic or at-risk people, to help prevent long-term complications of the condition. Diabetes-related complications are reduced by long term monitoring and tight control of blood glucose levels. Because red blood cells have a life span of 4 months, HbA1c gives an indication of long-term control of the patient's blood sugar levels and compliance with his/her diet.
Diabetes is a chronic and progressive disease that affects almost every aspect of life. The disease can result in premature death, ill health, and disability, conditions that can be prevented or delayed by high quality management and care.
Related Links:
Randox
Latest Clinical Chem. News
- Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
- Saliva-Based Test Detects Biochemical Signs of Sleep Loss
- Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
- Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
- Urine-Based Test Shows Promise for Autism Screening in Children
- Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s
- Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis
- Urine-Based Alzheimer’s Test Receives FDA Breakthrough Device Designation
- Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma
- New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
- Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
- International Experts Recommend Ending Routine 'Corrected' Calcium Reporting
- Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
- Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
- FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing
- CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics
Channels
Molecular Diagnostics
view channel
Blood-Based RNA Test May Predict Chemotherapy Sensitivity in Lung Cancer
Lung cancer care increasingly relies on biomarker-guided patient stratification, but tissue biopsy can be impractical and treatment selection remains difficult for many patients. Blood-based assays that... Read more
Blood Test Predicts Immunotherapy Response in Head and Neck Cancer
Head and neck squamous cell carcinoma affects hundreds of thousands of people worldwide each year, yet response rates to immunotherapy remain low. Clinicians lack reliable, minimally invasive tools to... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides
Meningiomas are the most common primary brain tumors in adults, yet their course ranges from indolent to highly recurrent disease. Estimating an individual patient’s recurrence risk often requires advanced... Read more
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency (AATD) is a progressive genetic condition, the leading known genetic risk factor for chronic obstructive pulmonary disease (COPD), and a cause of liver disease in both children... Read more








